• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Issues that matter
    • COVID-19 in India
    • Inadequate safe drinking water
    • Poor sanitation
    • Environmental health
    • Infectious disease
      • Hepatitis C
    • Noncommunicable Diseases (NCDs)
    • Malnutrition
    • High infant mortality
    • Mental health
    • Sex and gender discrimination
  • Special Focus
    • Interviews
      • Exclusive Interviews
      • Readers Interviews
    • Vaccine Hesitancy
  • News
  • PandemiCast
  • Partner’s Press Office

Health Issues India

Health issues in India

  • Home
  • About Us
  • Editorial Team
  • Subscribe
  • Contribute
  • Sponsor
  • Contact Us
You are here: Home / Featured / Mild COVID-19 cases: still at risk?

Mild COVID-19 cases: still at risk?

May 12, 2021 By Nicholas Parry Leave a Comment

COVID-19 is often only measured through the narrow scope of its mortality rate. While the death toll is undeniably high, some disregard the disease due to the mortality rate now being between a range of one and two percent. However, some individuals, even those with mild symptoms, can experience lasting effects.

World Health Organization WHO introduced new official name for Coronavirus disease named COVID-19. COVID-19 deaths illustrative. COVID-19 lockdown illustration. Deaths from COVID-19 illustration. COVID-19 pandemic concept. Image credit: quatrox / 123rf. infection with covid-19 concept
Image credit: quatrox / 123rf

So-called “Long COVID” is the concept of ongoing effects and symptoms far beyond the initial infection. Our understanding of this phase of the disease is constantly changing based on new information. Given the rapid pace at which the pandemic took hold, little could be said for a long period regarding the long term effects.

These ongoing symptoms are thought to be fairly common. As Health Issues India previously reported, regarding a study conducted on COVID-19 patients published in The Lancet, “76 percent of patients reported at least one ongoing symptom. Fatigue or muscle weakness was reported by 63 percent; 26 percent reported sleep difficulties; and 23 percent experienced anxiety or depression.”

A more recent Lancet study has added to this body of evidence. While previously assumed that only those with an initially severe COVID-19 infection developed long COVID symptoms, this appears to not be the case. Senior author, Professor Anton Pottegård from the University of Southern Denmark says 

“Until now, most research investigating long-term complications from COVID-19 has been focused on hospitalised patients. But the reality is that the majority of people with COVID-19 are not admitted to the hospital. Our study finds a very low risk of severe delayed effects from COVID-19 in people who didn’t require hospitalisation for the infection. However, our research provided evidence for some long-term effects that did not require hospitalisation or the use of new medicines, which we found reflected in higher use of primary health-care services after infection. This highlights the need to ensure clinicians have the resources and support to manage any potential long-term conditions.”

The study analysed data from the Danish health registries on all individuals who were tested for COVID-19 between Feb 27, 2020, and May 31, 2020. The study followed up 8,983 non-hospitalised COVID-19 positive people and 80,894 SARS-CoV-2-negative people during the period from two weeks to six months after the test. By comparing data from the two groups, researchers assessed the relative risk of starting new medications and of receiving a diagnosis of a new health condition during this time. The study took into account other factors that may increase the risk of more severe symptoms occurring during a COVID-19 infection, such as obesity, cancer, and kidney disease.

The study noted that “compared with individuals who tested negative, those with a positive SARS-CoV-2 test were at an increased risk of receiving a first diagnosis of breathing difficulties (1.2 percent compared with 0.7 percent) and blood clots in the veins (0.2 percent compared with 0.1 percent). No increased risk of serious complications identified by previous research conducted among individuals hospitalised for COVID-19, such as stroke, encephalitis, and psychosis, was identified among individuals who did not require hospitalisation.”

They also found that “those with a positive SARS-CoV-2 test visited their general practitioners around 20 percent (1.2 times) more often than those that tested negative, and visited outpatient clinics 10 percent (1.1 times) more often. However, there was no difference in the visits to [the] emergency department or being hospitalised.”

Limitations to the study were noted, specifically the fact that only symptoms that generated the need for contact with a hospital or medical services were noted. This leaves out minor symptoms such as fatigue or breathing issues that are not severe enough to warrant a visit to the hospital.

The study indicates that in those that tested positive for COVID-19, but were not hospitalised, there lies an increased risk of further complications in the coming months. However, it does appear to suggest that these complications were rarely severe, as visits to the emergency department were not increased in this group. 

The findings underline a considerable issue in India. Hospitals are already overwhelmed by COVID-19 cases. Due to the rapid increase in cases associated with the second wave, individuals seeking medical attention for long COVID symptoms may persist for months, further adding to the burden.

The findings have already been confirmed across numerous countries, with doctors and researchers noting that the long COVID symptoms are not isolated to the elderly or the vulnerable. Many noted that the symptoms present themselves in young people who have no prior medical history, with symptoms such as irregular heartbeats and autonomic dysfunction.

What is clear is that India has a long way to go in addressing COVID-19 cases. As cases remain at an all time high the issue could potentially extend far beyond the initial cases. The hospital system and systemic infrastructure issues must be addressed if a colossal death toll is to be averted.

 

Filed Under: Featured, Infectious diseases, Medicine and Research, News Tagged With: coronavirus, COVID-19, Long COVID

About Nicholas Parry

Nicholas Parry has a Bachelor of Science in genetics from the University of Sheffield and a Master of Research in neuroscience from the University of Nottingham. He has been a featured writer for Health Issues since 2016. He is based in South Wales.

Reader Interactions

Leave a Reply Cancel reply

You must be logged in to post a comment.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Primary Sidebar

Articles

  • Renewed fears of a bird flu pandemic; The latest health stories from around the world
  • More oversight needed for “gain of function” research says expert panel; The latest health stories from around the world
  • Marion Biotech to be investigated by Indian drug regulator
  • Sesame to be added to list of major food allergens
  • Approval of Alzheimer’s drug “rife with irregularities”

Footer

Archives

Issues that matter

  • Environmental health
  • Inadequate safe drinking water
  • Poor sanitation
  • Infectious disease
  • Noncommunicable Diseases (NCDs)
  • Malnutrition
  • High infant mortality

Categories

Copyright © 2023 · News Pro On Genesis Framework · WordPress · Log in

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies. However you may visit Cookie Settings to provide a controlled consent.
Cookie settingsACCEPTACCEPT ALL
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.